Cargando…
Evolution and diabetic vasculopathy
Evolution of blood sugar, glycation, receptor for advanced glycation end‐products and diabetic vasculopathy.[Image: see text]
Autores principales: | Yamamoto, Hiroshi, Yamamoto, Yasuhiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248414/ https://www.ncbi.nlm.nih.gov/pubmed/35598317 http://dx.doi.org/10.1111/jdi.13843 |
Ejemplares similares
-
Receptor for advanced glycation end‐products‐mediated inflammation and diabetic vascular complications
por: Yamamoto, Yasuhiko, et al.
Publicado: (2011) -
COVID-19-associated vasculitis and vasculopathy
por: Becker, Richard C.
Publicado: (2020) -
RAGE-Mediated Inflammation, Type 2 Diabetes, and Diabetic Vascular Complication
por: Yamamoto, Yasuhiko, et al.
Publicado: (2013) -
The role of everolimus in treatment of cardiac allograft vasculopathy
por: Watanabe, Tetsu
Publicado: (2013) -
Epigenetic basis of diabetic vasculopathy
por: Bhamidipati, Theja, et al.
Publicado: (2022)